Berkshire Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Hold
3,448
0.01% 236
2025
Q4
$274K Sell
3,448
-150
-4% -$11.8K 0.01% 227
2025
Q3
$271K Buy
3,598
+156
+5% +$10.7K 0.01% 254
2025
Q2
$237K Sell
3,442
-31
-0.9% -$2.03K 0.01% 256
2025
Q1
$236K Buy
+3,473
New +$208K 0.01% 258
2024
Q4
Sell
-4,762
Closed -$281K 290
2024
Q3
$281K Hold
4,762
0.01% 241
2024
Q2
$281K Buy
4,762
+561
+13% +$35.1K 0.01% 242
2024
Q1
$335K Sell
4,201
-48
-1% -$3.67K 0.02% 190
2023
Q4
$336K Hold
4,249
0.02% 187
2023
Q3
$297K Sell
4,249
-200
-4% -$14.2K 0.02% 194
2023
Q2
$308K Buy
4,449
+351
+9% +$25K 0.02% 192
2023
Q1
$305K Buy
+4,098
New +$344K 0.02% 186
2022
Q4
Sell
-3,444
Closed -$328K 159
2022
Q3
$328K Buy
3,444
+9
+0.3% +$891 0.02% 164
2022
Q2
$318K Buy
3,435
+14
+0.4% +$1.37K 0.02% 177
2022
Q1
$346K Sell
3,421
-10
-0.3% -$1.05K 0.02% 163
2021
Q4
$354K Sell
3,431
-390
-10% -$36K 0.02% 191
2021
Q3
$324K Buy
3,821
+603
+19% +$50.5K 0.02% 193
2021
Q2
$269K Hold
3,218
0.02% 202
2021
Q1
$242K Sell
3,218
-191
-6% -$13.9K 0.02% 208
2020
Q4
$233K Buy
+3,409
New +$222K 0.02% 201
2020
Q3
Sell
-5,689
Closed -$370K 168
2020
Q2
$370K Sell
5,689
-1,012
-15% -$63.7K 0.03% 124
2020
Q1
$398K Buy
6,701
+1,041
+18% +$69.5K 0.04% 137
2019
Q4
$420K Sell
5,660
-283
-5% -$19.9K 0.04% 133
2019
Q3
$375K Sell
5,943
-1,695
-22% -$100K 0.03% 156
2019
Q2
$416K Buy
7,638
+1,794
+31% +$96.6K 0.03% 149
2019
Q1
$315K Sell
5,844
-318
-5% -$19.6K 0.03% 183
2018
Q4
$404K Buy
6,162
+796
+15% +$59.4K 0.04% 152
2018
Q3
$422K Sell
5,366
-50
-0.9% -$3.58K 0.04% 156
2018
Q2
$349K Sell
5,416
-613
-10% -$40.4K 0.03% 166
2018
Q1
$375K Sell
6,029
-16
-0.3% -$1.15K 0.04% 152
2017
Q4
$438K Buy
6,045
+657
+12% +$47.8K 0.04% 146
2017
Q3
$438K Buy
5,388
+15
+0.3% +$1.19K 0.05% 133
2017
Q2
$432K Hold
5,373
0.05% 133
2017
Q1
$422K Sell
5,373
-200
-4% -$16K 0.05% 134
2016
Q4
$440K Buy
5,573
+643
+13% +$52K 0.06% 125
2016
Q3
$439K Buy
4,930
+77
+2% +$7.27K 0.06% 126
2016
Q2
$465K Buy
4,853
+1,465
+43% +$146K 0.07% 122
2016
Q1
$351K Sell
3,388
-89
-3% -$8.65K 0.05% 123
2015
Q4
$340K Buy
3,477
+20
+0.6% +$1.96K 0.06% 120
2015
Q3
$334K Hold
3,457
0.06% 120
2015
Q2
$363K Sell
3,457
-80
-2% -$8.17K 0.06% 122
2015
Q1
$365K Sell
3,537
-808
-19% -$81.8K 0.06% 122
2014
Q4
$418K Hold
4,345
0.07% 113
2014
Q3
$346K Hold
4,345
0.06% 128
2014
Q2
$327K Buy
4,345
+205
+5% +$15.5K 0.06% 130
2014
Q1
$310K Sell
4,140
-517
-11% -$36.5K 0.06% 128
2013
Q4
$333K Buy
+4,657
New +$299K 0.06% 134

Other funds holding CVS

Berkshire Asset Management's CVS Position: Q1 2026 in Review

Berkshire Asset Management held its CVS Health (CVS) position steady in Q1 2026 at 3,448 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #236.

Berkshire Asset Management first reported a position in CVS in Q4 2013 and has held it in 47 quarters since. The position peaked at $465K in Q2 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Berkshire Asset Management held 3,448 shares of CVS Health worth $248K as of Q1 2026.
  • Berkshire Asset Management left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up 0.01% of Berkshire Asset Management's portfolio in Q1 2026, its #236 holding.
  • Berkshire Asset Management first reported a position in CVS Health in Q4 2013 and has held it in 47 quarters since.
  • Berkshire Asset Management's CVS Health position peaked at $465K in Q2 2016.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.